**Core Concept**
Late East African Trypanosomiasis, also known as Gambian trypanosomiasis, is a severe form of African trypanosomiasis caused by the parasite *Trypanosoma brucei rhodesiense*. The disease is characterized by a range of neurological and cardiac symptoms, and requires prompt and effective treatment to prevent mortality.

**Why the Correct Answer is Right**
The drug of choice for Late East African Trypanosomiasis is **Melarsoprol**, a potent arsenical compound that acts by inhibiting the parasite's glycolytic enzymes, ultimately leading to the death of the parasite. Melarsoprol is administered intravenously and has a narrow therapeutic window, requiring close monitoring for adverse effects. The drug works by accumulating within the parasite, where it interferes with the glycolytic pathway, ultimately leading to the parasite's death.

**Why Each Wrong Option is Incorrect**
**Option A:** **Eflornithine** is used in the treatment of West African trypanosomiasis, not Late East African trypanosomiasis. Eflornithine works by inhibiting the enzyme ornithine decarboxylase, which is involved in the synthesis of polyamines.
**Option B:** **Suramin** is used in the early stage of East African trypanosomiasis, but is not effective in the late stage of the disease. Suramin works by inhibiting the parasite's glycolytic enzymes, but its effectiveness is limited in the late stage of the disease.
**Option C:** **Nifurtimox** is used in combination with Eflornithine for the treatment of West African trypanosomiasis, but is not the drug of choice for Late East African Trypanosomiasis. Nifurtimox works by generating reactive oxygen species that damage the parasite.

**Clinical Pearl / High-Yield Fact**
In the treatment of Late East African Trypanosomiasis, it is essential to monitor for adverse effects of Melarsoprol, including encephalopathy, seizures, and coagulopathy. The drug should be administered under close medical supervision, and patients should be monitored for signs of toxicity.

**Correct Answer:** C.